Abstract
The aim of this study was to analyse the clinical characteristics and outcome of children diagnosed with Ph+ ALL. A total of 2591 newly diagnosed ALL children were treated in Poland between the years 2005 and 2017. Of those, 44 were diagnosed with Ph(+) ALL. The patients were treated according to protocols: ALL IC-BFM 2002 and 2009 (26 patients), EsPhALL (12 patients), initially ALL IC-BFM and then EsPhALL (6 patients). The median of follow-up in the observed group was 3 years. Overall survival (OS) and event-free survival (EFS) of Ph+ ALL group were 0.73 and 0.64. OS and EFS of patients after HSCT were 0.78 and 0.66, while without HSCT were 0.6 and 0.6, P = 0.27 and 0.63. OS was 0.8 for patients treated with chemotherapy plus imatinib and 0.61 for chemotherapy alone, P = 0.22, while EFS was 0.66 (imatinib therapy) and 0. 61 (without imatinib), P = 0.41. Our study suggests that adding imatinib to intensive chemotherapy seems to improve outcome. However, this study was limited by a small number of patients and a variety of chemotherapy regimens with or without imatinib.
References
Aug 16, 2005·British Journal of Haematology·Louise K Jones, Vaskar Saha
Jul 22, 2009·Pediatric Blood & Cancer·Michael J BurkeRichard Kadota
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirk R SchultzBruce Camitta
Aug 18, 2012·The Lancet Oncology·Andrea BiondiMaria Grazia Valsecchi
May 15, 2013·Hematology/oncology and Stem Cell Therapy·Khadra SalamiFaris Madanat
Dec 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan StaryMartin Schrappe
Dec 25, 2013·Blood·Arian van der VeerGiovanni Cazzaniga
Jan 21, 2014·Leukemia·K R SchultzUNKNOWN Children’s Oncology Group
Feb 7, 2014·Cancer·Sima JehaDario Campana
Feb 3, 2015·Cancer Medicine·Atsushi ManabeKeizo Horibe
Mar 6, 2015·Haematologica·Veronica Leoni, Andrea Biondi
May 2, 2015·Journal of Pediatric Hematology/oncology·Ryoko SuzukiTakashi Fukushima
Jun 28, 2016·Cancer Genetics·Marie JarosovaVladimir Mihal
Jan 14, 2017·Pediatric Blood & Cancer·Yuichi KodamaHiroyuki Shimada
Jun 9, 2017·Korean journal of pediatrics·Jae Wook Lee, Bin Cho
Oct 29, 2017·Haematologica·Giovanni CazzanigaAndrea Biondi
Feb 6, 2018·Clinical Lymphoma, Myeloma & Leukemia·Ali M Al-Amri
Mar 10, 2018·Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University·Małgorzata Janeczko-CzarneckaKrzysztof Kałwak
Citations
May 15, 2020·Journal of Medical Virology·Joanna ZawitkowskaJan Styczyński
Jul 10, 2020·Leukemia & Lymphoma·Kangkang LiuNingling Wang
Apr 9, 2019·Blood Research·Juae ShinBin Cho
Oct 31, 2020·Medicine·Joanna ZawitkowskaAgnieszka Zaucha-Prażmo